Symmetry Peak Management LLC Catalyst Pharmaceuticals, Inc. Transaction History
Symmetry Peak Management LLC
- $91.4 Million
- Q4 2024
A detailed history of Symmetry Peak Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Symmetry Peak Management LLC holds 15,000 shares of CPRX stock, worth $342,000. This represents 0.14% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$342,000% of portfolio
0.14%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CPRX
# of Institutions
354Shares Held
98.7MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$426 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$192 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$132 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$71.4 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$68.7 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.34B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...